compat
safeti
interact
antibodi
induct
combin
vaccin
applic
assess
specif
pathogenfre
cat
vaccin
either
modifi
live
viru
vaccin
contain
felin
calici
fcv
herp
parvoviru
fpv
chlamydophila
feli
c
feli
adjuv
recombin
felin
leukaemia
viru
felv
vaccin
vaccin
one
syring
combin
applic
felv
elisa
antibodi
titr
unalt
howev
antibodi
product
base
indirect
immunofluoresc
assay
remark
enhanc
fcv
select
time
point
also
enhanc
c
feli
diminish
fpv
use
vaccin
combin
safe
simplifi
vaccin
schedul
veterinari
practic
vaccin
use
felin
medicin
sinc
earli
often
repres
safest
effect
way
protect
cat
mani
major
felin
infecti
diseas
vaccin
far
possibl
free
advers
side
effect
show
high
antigen
practic
reason
becom
common
combin
sever
felin
vaccin
within
singl
syring
therebi
reduc
anim
injectionrel
stress
well
cost
differ
antigen
present
mixtur
inocul
simultan
competit
respect
stimul
immun
system
may
occur
howev
combin
applic
could
also
augment
modul
qualiti
immun
respons
elicit
therefor
differ
immunogen
combin
one
inject
immunogen
individu
antigen
evalu
gener
vaccin
contain
live
organ
potenti
rais
longlast
immun
induc
stronger
cellular
immun
respons
inactiv
counterpart
improv
antigen
inactiv
recombin
vaccin
adjuv
substanc
stimul
earli
process
immun
recognit
particularli
inflammatori
respons
use
adjuv
influenc
gener
helper
th
lymphocyt
subset
magnitud
immun
respons
aim
studi
assess
antibodi
induct
kitten
combin
administr
singl
inject
multival
modifi
live
viru
mlv
vaccin
felin
caliciviru
fcv
felin
felin
parvoviru
fpv
chlamydophila
feli
c
feli
adjuv
recombin
felin
leukaemia
viru
felv
vaccin
success
result
studi
also
use
part
submiss
regulatori
purpos
preliminari
vaccin
compat
test
vitro
perform
evalu
effect
aluminium
hydroxid
adjuv
contain
felv
vaccin
viabil
attenu
live
vaccin
compon
immunogen
mlv
compon
c
feli
combin
test
vivo
assay
antibodi
variou
vaccin
antigen
safeti
vaccin
assess
observ
record
system
local
advers
reaction
simultan
inject
vaccin
adjuv
includ
recombin
felv
vaccin
known
stimul
immun
respons
presenc
vaccin
might
effect
compon
inject
togeth
order
character
tlymphocyt
respons
differ
group
express
mrna
evalu
lymphocyt
c
felisantigen
stimul
cona
stimul
mockstimul
vitro
c
feli
antigen
select
model
stimulan
present
mlv
vaccin
could
handl
readili
thirti
specif
pathogenfre
spf
kitten
provid
liberti
research
inc
waverli
ny
usa
cat
assign
randomli
regardless
sex
three
group
anim
avoid
famili
cluster
group
vaccin
use
commerci
batch
nobivac
forcat
nobivac
felv
intervet
uk
ltd
nobivac
forcat
modifi
live
vaccin
contain
fcv
fpv
c
feli
without
adjuv
studi
viral
chlamydi
dose
adjust
pfu
fcv
strain
pfu
strain
tcid
fpv
strain
tcid
c
feli
baker
strain
adjust
done
order
compli
regulatori
requir
state
vaccin
end
shelf
life
must
contain
abovement
dose
nobivac
felv
recombin
vaccin
contain
felv
antigen
nonglycosyl
protein
fraction
viru
envelop
glycoprotein
consid
respons
induct
protect
antibodi
dose
nobivac
felv
contain
g
purifi
molecul
antigen
materi
adjuv
aluminium
hydroxid
gel
deriv
quil
purifi
deriv
saponin
combin
applic
vaccin
one
dose
lyophilis
nobivac
forcat
reconstitut
one
dose
nobivac
felv
influenc
felv
vaccin
viabil
modifi
live
vaccin
compon
evalu
vitro
live
microbi
vaccin
compon
fcv
fpv
c
feli
individu
reconstitut
either
felv
vaccin
solvent
titrat
crandel
felin
kidney
crfk
cell
viral
compon
mccoy
cell
c
feli
describ
titrat
vaccin
compon
took
place
either
immedi
reconstitut
vaccin
suspens
held
room
temperatur
min
respect
titr
vaccin
compon
calcul
method
reed
muench
prior
vaccin
conjunctiv
oropharyng
nasal
rectal
swab
cat
collect
test
polymeras
chain
reaction
pcr
order
confirm
spfstatu
cat
use
studi
respect
follow
pathogen
fcv
fpv
felin
coronaviru
fcov
c
feli
blood
sampl
taken
day
order
detect
possibl
presenc
antibodi
vaccin
antigen
verifi
lack
felv
antigenaemia
cat
vaccin
age
week
subcutan
inject
shoulder
blade
ml
antigen
materi
accord
group
assign
day
anim
group
n
receiv
nobivac
forcat
nobivac
felv
appli
togeth
one
singl
syring
anim
group
n
receiv
nobivac
forcat
alon
anim
group
n
administ
nobivac
felv
cat
given
second
vaccin
interv
day
accord
recommend
schedul
primari
immunis
kitten
cat
monitor
immedi
inject
vaccin
daili
local
system
reaction
vaccin
rectal
temperatur
record
h
inocul
inject
site
examin
advers
reaction
h
postvaccin
daili
thereaft
degre
swell
categor
one
four
class
swell
observ
discret
swell
mm
signific
diffus
thicken
swell
approxim
swell
mm
kitten
weight
record
weekli
throughout
studi
blood
specimen
obtain
eight
differ
time
point
day
jugular
venepunctur
use
ml
dispos
syring
omnifix
b
braun
germani
aliquot
blood
l
immedi
transfer
ml
k
edta
micro
tube
sarstedt
germani
use
haematolog
test
remain
blood
transfer
evacu
tube
ml
bd
sst
glass
vacutain
becton
dickinson
ag
switzerland
use
serum
prepar
clot
blood
sampl
centrifug
aliquot
serum
taken
clinic
biochem
analysi
remain
serum
store
c
requir
test
day
ml
blood
collect
evacu
tube
contain
heparin
lithium
heparin
vacutain
becton
dickinson
order
characteris
respons
lymphocyt
nonspecif
c
felisantigen
stimul
vitro
measur
transcript
select
cytokin
serum
sampl
test
presenc
antibodi
fcv
fpv
c
feli
immunofluoresc
assay
ifa
felv
enzymelink
immunosorb
assay
elisa
respect
total
nucleic
acid
extract
swab
conjunctiv
oropharyng
nasal
rectal
swab
blood
use
magna
pure
lc
total
nucleic
acid
isol
kit
magna
pure
lc
instrument
roch
diagnost
ag
rotkreuz
switzerland
accord
manufactur
recommend
two
hundr
microlit
pb
sigma
st
loui
mo
usa
ad
ml
microcentrifug
tube
contain
swab
sampl
vortex
sampl
incub
c
min
incub
microcentrifug
tube
spun
g
min
swab
invert
recentrifug
g
min
swab
discard
whole
eluat
use
extract
total
nucleic
acid
extract
total
nucleic
acid
analys
onetub
realtim
taqman
pcr
revers
transcriptas
rt
pcr
use
sequenc
detect
system
abi
appli
biosystem
rotkreuz
switzerland
swab
test
presenc
fcv
use
modifi
protocol
follow
primer
probe
describ
help
forward
primer
revers
primer
microsynth
ag
balgach
switzerland
probe
eurogentec
sera
belgium
detect
fpv
fcov
c
feli
perform
use
pcr
describ
elsewher
felv
antigen
serum
assay
sandwich
elisa
base
monoclon
antibodi
describ
lutz
et
al
serum
sampl
analys
presenc
antibodi
fcv
fpv
ifa
describ
previous
semiconflu
crfk
cell
monolay
infect
fcv
strain
strain
fpv
strain
respect
viru
strain
ident
contain
combin
modifi
live
vaccin
antigen
prepar
test
absenc
contamin
virus
rtpcr
pcr
fcv
fpv
fcov
describ
felv
fiv
found
posit
antigen
intend
present
cultur
serum
sampl
test
dilut
fcv
fpv
detect
antibodi
c
feli
carri
microtitr
plate
titrat
serum
sampl
substrat
consist
methanolfix
mccoy
cell
cellsml
infect
c
feli
tcid
ml
wash
unbound
antibodi
pb
antibodi
bound
c
feli
detect
incub
well
goat
anticat
immunoglobulin
fluorescein
isothiocyanat
conjug
kirkegaard
perri
laboratori
gaithersburg
usa
subsequ
glycerol
pb
ad
well
plate
examin
uvlight
microscop
posit
fluoresc
chlamydi
inclus
antibodi
titr
express
reciproc
last
serum
dilut
show
posit
fluoresc
ifa
antibodi
felv
nonglycosyl
form
measur
elisa
describ
elsewher
complet
haematolog
analys
perform
routin
procedur
use
automat
electron
cell
counter
celldyn
abbott
baar
switzerland
bilirubin
glucos
urea
creatinin
protein
albumin
cholesterin
alkalin
phosphatas
aspart
aminotransferas
alanin
aminotransferas
lipas
sodium
potassium
chlorid
calcium
phosphoru
assay
autom
analysi
cobasintegra
roch
diagnost
ag
accord
standard
procedur
recommend
intern
feder
clinic
chemistri
tlymphocyt
respons
differ
vitro
stimul
character
quantifi
variou
cytokin
mrna
transcript
realtim
rtpcr
preexperi
differ
stimul
protocol
perform
order
determin
best
condit
suitabl
stimul
felin
pbmc
pbmc
incub
either
gml
con
type
iv
sigma
gml
phytohemagglutinin
pha
form
gibco
brl
life
technolog
paisley
scotland
ngml
phorbol
pma
sigma
ngml
ionomycin
sigma
condit
describ
subsequ
pbmc
isol
ml
heparinis
blood
collect
week
second
vaccin
densiti
gradient
centrifug
ficollhypaqu
densiti
sigma
mononuclear
cell
fraction
resuspend
ml
rpmi
medium
gibcobrl
supplement
fetal
calf
serum
gibco
uml
penicillin
gml
streptomycin
gibco
uml
recombin
human
sigma
cell
suspens
three
cell
cultur
per
cat
initi
plate
cell
densiti
cellswel
cell
stimul
either
l
cell
cultur
medium
control
g
con
sigma
nonspecif
stimul
l
chlamydophilaantigen
specif
stimul
felin
chlamydophilaantigen
semipurifi
prepar
produc
follow
felin
chlamydophila
baker
strain
materi
overlaid
top
urograffin
gradient
schere
burgess
hill
great
britain
result
pellet
resuspend
pb
subsequ
run
urograffin
gradient
fraction
collect
screen
elisa
maximum
antigen
content
use
standard
method
antigen
use
tcell
stimul
consist
fraction
show
highest
activ
elisa
cell
incub
h
c
co
incub
cell
pellet
centrifug
lyse
directli
plate
addit
l
lysi
buffer
magna
pure
lc
mrna
isol
kit
roch
diagnost
ag
sampl
transfer
ml
microcentrifug
tube
store
c
use
mrna
isol
cultur
cell
magna
pure
lc
use
mrna
isol
kit
mrna
cell
protocol
accord
manufactur
recommend
roch
diagnost
ag
transcript
interleukin
il
interferon
gamma
well
housekeep
gene
code
dehydrogenas
gapdh
quantit
rtpcr
describ
mrna
transcript
detect
rtpcr
use
sens
primer
antisens
primer
microsynth
ag
probe
eurogentec
thermal
assay
condit
use
measur
mrna
transcript
cytokin
test
primer
probe
concentr
nm
nm
respect
transcript
differ
cytokin
gapdh
assay
run
cat
minimis
interassay
variat
quantit
analysi
cytokin
mrna
concentr
normalis
relat
felin
gapdh
set
theoret
valu
gene
copi
statist
analys
antibodytitr
carri
use
mannwhitney
utest
perform
use
graphpad
prism
version
window
graphpad
softwar
san
diego
ca
usa
pvalu
consid
signific
haematolog
biochem
paramet
analys
signific
differ
group
p
kruskalw
test
statview
sa
institut
inc
cari
nc
usa
comparison
differ
stimul
cytokin
assay
perform
use
kruskalw
test
follow
dunn
multipl
comparison
posttest
graphpad
prism
version
titr
modifi
live
vaccin
compon
reconstitut
either
felv
vaccin
solvent
significantli
differ
tabl
even
incub
h
room
temperatur
signific
titr
decreas
observ
evid
infect
pathogen
assay
fcv
fpv
felv
fcov
c
feli
found
sampl
collect
prior
vaccin
follow
vaccin
system
reaction
clinic
sign
observ
cat
vaccin
group
rectal
temperatur
measur
h
inocul
daili
thereaft
end
studi
never
exceed
physiolog
rang
cat
c
data
shown
signific
differ
temperatur
curv
three
group
data
shown
inject
site
examin
advers
reaction
h
postvaccin
daili
thereaft
cat
group
receiv
felv
vaccin
first
h
vaccin
show
total
mean
score
respect
significantli
higher
p
mean
score
observ
cat
group
vaccin
modifi
live
vaccin
alon
local
reaction
score
combin
first
h
vaccin
exceed
score
except
cat
group
cumul
score
respect
howev
swell
readili
disappear
spontan
within
day
kitten
gain
weight
constantli
throughout
studi
irrespect
vaccin
group
antibodi
respons
differ
vaccin
antigen
measur
group
interv
start
day
first
vaccin
day
week
complet
primari
immunis
day
fig
antibodi
titr
fcv
significantli
higher
day
cat
receiv
combin
vaccin
group
compar
cat
vaccin
multival
live
vaccin
group
fig
p
antibodi
titr
significantli
higher
cat
group
day
fig
signific
differ
found
antibodi
titr
fpv
cat
group
except
day
p
p
anim
receiv
combin
vaccin
lower
median
titr
fig
cat
group
produc
compar
median
antibodi
titr
c
feli
except
day
p
fig
vaccin
induc
compar
antibodi
level
felv
group
except
day
fig
chang
relat
vaccin
measur
haematolog
biochem
paramet
observ
data
shown
except
white
blood
cell
wbc
count
cat
group
vaccin
multival
mlv
vaccin
show
significantli
decreas
number
wbc
week
first
vaccin
day
p
differenti
blood
count
reveal
reduct
wbc
group
mostli
due
transient
lymphopenia
mean
lymphocyt
count
group
group
group
p
group
lesser
degre
decreas
neutrophil
count
mean
neutrophil
count
group
group
group
p
group
monocyt
eosinophil
data
shown
pbmc
isol
cat
test
mrna
level
cytokin
cytokin
respons
chlamydophilaantigen
purpos
experi
characteris
type
immun
respons
induc
c
feli
vaccin
antigen
fig
pbmc
collect
cat
group
combin
vaccin
produc
higher
level
specif
mrna
con
c
felisantigen
stimul
compar
cat
group
p
howev
signific
differ
express
also
observ
unstimul
lymphocyt
p
interest
note
express
level
mean
valu
lymphocyt
cat
group
stimul
c
feli
antigen
nonstimul
lymphocyt
differ
fig
middl
right
graph
p
howev
level
mrna
express
lymphocyt
group
higher
c
feli
antigen
stimul
unstimul
lymphocyt
group
cat
p
pattern
express
similar
mrna
synthesi
differ
found
mrna
level
lymphocyt
stimul
c
feli
nonstimul
lymphocyt
p
differ
transcript
observ
among
group
increas
express
found
c
felisstimul
cat
group
p
howev
similar
increas
also
seen
unstimul
lymphocyt
p
studi
question
evalu
whether
mlv
vaccin
could
inject
togeth
one
syring
recombin
felv
vaccin
without
loss
antigen
compar
singl
immun
cat
mlv
felv
vaccin
end
three
group
cat
vaccin
would
interest
includ
forth
group
cat
would
vaccin
mlv
felv
vaccin
separ
inject
site
veterinarian
focuss
use
singl
inject
mean
includ
forth
group
question
immun
respons
forth
group
answer
safetyrel
assess
vaccin
adjuv
includ
serum
biochemistri
haematolog
inject
site
observ
combin
administr
multival
mlv
vaccin
felv
vaccin
caus
notic
increas
side
effect
compar
administr
separ
compon
induc
undesir
system
reaction
fever
depress
loss
appetit
local
reaction
vaccin
observ
cat
group
local
inflammatori
reaction
almost
certainli
caus
felv
vaccin
probabl
relat
aluminium
quil
adjuv
howev
side
effect
littl
clinic
relev
swell
inject
site
compar
induc
singl
applic
felv
vaccin
disappear
without
treatment
within
day
aluminium
hydroxid
depotform
adjuv
induc
format
macrophagerich
granuloma
vaccin
inject
site
prolong
antigen
stimulu
adjuv
felv
vaccin
compon
nontox
fraction
quil
qs
deriv
bark
south
american
tree
quillaja
saponaria
signific
adjuv
activ
haematolog
biochem
chang
observ
vaccin
except
transient
leukopenia
week
first
vaccin
day
group
vaccin
multival
mlv
vaccin
transient
leukopenia
probabl
caus
fpv
compon
vaccin
also
observ
other
may
correspond
transient
leukopenia
observ
infect
virul
fpv
field
condit
vaccin
thu
well
toler
cat
combin
applic
well
singl
applic
vaccin
took
place
day
antibodi
fcv
fpv
c
feli
determin
ifa
median
titr
depict
antibodi
recombin
antigen
felv
determin
elisa
given
percentag
posit
control
group
e
group
statist
compar
signific
differ
mannwhitney
utest
p
fig
express
mrna
b
c
con
stimul
c
felisantigen
stimul
unstimul
pbmc
cultur
cytokin
express
normalis
gapdh
set
theoret
valu
gene
copi
statist
analysi
perform
use
kruskalw
dunn
multipl
comparison
test
p
p
p
ns
significantli
differ
efficaci
antibodi
induct
combin
vaccin
applic
compar
follow
vaccin
either
vaccin
alon
remark
antibodi
product
fcv
select
time
point
c
feli
induc
vaccin
significantli
higher
combin
vaccin
singl
vaccin
multival
mlv
vaccin
group
cat
antibodi
titr
fcv
fpv
somewhat
declin
versu
end
observ
period
especi
fpv
second
vaccin
firm
explan
decreas
offer
specul
repres
natur
declin
exposur
antigen
peak
high
level
cat
group
vaccin
sole
felv
vaccin
low
titr
fcv
observ
day
group
complet
separ
low
titr
like
indic
cat
becam
infect
fcv
inadvert
rather
nonspecif
immunofluoresc
reaction
observ
low
serum
dilut
inform
avail
respect
correl
antibodi
titr
found
cat
protect
field
viru
infect
observ
combin
vaccin
group
induc
antibodi
titr
similar
even
higher
cat
group
respect
suggest
similar
degre
protect
field
condit
expect
might
expect
combin
live
attenu
virus
quil
fraction
qs
would
result
inactiv
envelop
possibl
also
nonenvelop
fcv
fpv
deterg
properti
howev
vitro
compat
studi
show
viabil
four
live
compon
multival
vaccin
impair
combin
felv
vaccin
interestingli
vivo
antibodi
titr
fpv
somewhat
reduc
group
two
occas
day
explan
offer
observ
well
known
parvovirus
extrem
resist
deterg
difficult
imagin
adjuv
alter
viabil
fcv
partial
inactiv
parvovirus
antibodi
titr
felv
similar
cat
receiv
combin
singl
vaccin
regimen
respect
observ
cat
group
show
ident
antibodi
kinet
titr
felv
surpris
group
natur
amount
adjuv
ident
cat
produc
antibodi
vaccin
antigen
although
seroconvers
proof
virus
fact
replic
replic
must
postul
three
mlv
compon
fcv
fpv
inactiv
titr
would
undoubtedli
much
lower
antigen
mass
virus
probabl
small
antibodi
induct
protect
intracellular
bacteria
c
feli
mediat
macrophag
activ
cytotox
cell
ie
cellmedi
immun
previous
observ
vaccin
contain
live
organ
abl
induc
protect
immun
intracellular
bacteria
pbmc
cultur
lymphocyt
stimul
produc
particularli
group
express
equal
group
independ
mode
stimul
interestingli
increas
express
lymphocyt
group
observ
c
felisstimul
parallel
increas
express
unstimul
lymphocyt
ratio
express
lymphocyt
c
felisstimul
stimul
made
order
elimin
influenc
vivo
cell
stimul
differ
group
degre
express
c
felisstimul
found
observ
suggest
lymphocyt
cat
group
alreadi
stimul
vivo
possibl
due
combin
mlv
compon
adjuv
felv
vaccin
adjuv
contain
immunomodul
fraction
adjuv
quil
shown
enhanc
significantli
antibodi
cellmedi
immun
respons
aluminium
hydroxid
adjuv
promot
primarili
humor
bias
immun
respons
interestingli
lymphocyt
group
cat
stimul
c
feli
express
significantli
higher
level
unstimul
lymphocyt
also
suggest
adjuv
felv
vaccin
induc
vivo
activ
lymphocyt
readili
induc
conclus
result
indic
use
multival
mlv
vaccin
chlamydophil
compon
combin
recombin
felv
vaccin
safe
loss
antigen
observ
combin
applic
even
result
higher
antibodi
respons
fcv
c
feli
compon
latter
observ
explain
immunostimul
effect
adjuv
contain
felv
vaccin
